Biologic API CDMO Benchmarking (10th Ed.)

Report Overview

ISR’s Biologic API CDMO Benchmarking (10th Edition) report brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CDMO decisions, and help CDMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CDMO service quality across a series of 23 performance attributes specific to outsourced drug substance manufacturing. In this Consumer Reports-style analysis, ISR presents data on 412 service encounters from 147 respondents who have been involved in outsourced biologic API projects in the past 18 months.

What you will learn:

Drug Developers:

• Uncover which CDMO attributes drive outsourcing partner selection for outsourced bioprocessing as well as which CDMO attributes have gained importance over the past 12 months among industry peers
• Gain insight into CDMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience
• Make a more educated purchase of CDMO services by understanding which manufacturers best fit your company’s needs in addition to how individual CDMOs have measured up to sponsor-peer expectations on similar projects

Contract Manufacturers:

• Compare your company’s performance against its competitors across 23 metrics specific to outsourced bioprocessing
• Gain insight into drug developers’ outsourcing preferences and practices when it comes to CDMO selection and CDMO preference for outsourced biologic API manufacturing
• Understand your company’s competitive position as well as its delivery strengths and weaknesses, then use the information to develop targeted messaging on true areas of strength

Major Sections:

• Outsourcing Philosophies & Practices
• CDMO Selection Drivers
• CDMO Perceptions & Interactions
• CDMO Performance & Loyalty
• The Biologic API CDMO Competitive Landscape
• Company Service Quality Profiles
• Appendix
• CDMO Drill-Downs
• Demographics

Included Providers:

• AbbVie Contract Manufacturing
• Abzena
• AGC Biologics
• Ajinomoto Bio-Pharma Services
• Avid Bioservices
• Axplora
• Bionova
• Boehringer Ingelheim BioXcellence
• Bora Pharmaceuticals
• Catalent
• Celonic
• Curia
• Cytovance Biologics
• FujiFilm Diosynth Biotechnologies
• Genscript ProBio
• Global Biotech Cooperations
• GSK Contract Manufacturing
• Hetero Biopharma
• IDT Biologika
• Just – Evotec Biologics
• KBI Biopharma
• Lonza
• MilliporeSigma
• Olon
• Patheon, by Thermo Fisher Scientific
• Pfizer CentreOne
• Rentschler
• Resilience
• Samsung Biologics
• Sandoz
• Scorpius Biomanufacturing
• Syngene
• Wockhardt
• WuXi Biologics

Companies listed in bold print have been reviewed by 10 or more respondents. These providers have detailed company service quality profiles and are included in an in-depth performance analysis.